Acute Pancreatitis CT Reporting: Collections, Complications and Examples

Why timing matters in acute pancreatitis CT reporting

The report should describe pancreatic parenchyma and peripancreatic change, then separately characterize any necrosis, collections, vascular complications, and effects on adjacent organs. When available, record the time from symptom onset to CT in the clinical context. Early imaging may not show the full extent of necrosis.

The 2024 American College of Gastroenterology (ACG) guideline recommends CT/MRI when the diagnosis is unclear or the patient has not improved clinically within 48–72 hours; it does not support routine admission CT to grade severity. The 2025 International Association of Pancreatology (IAP) guideline recommends initial CT for diagnostic uncertainty, failure to respond, or clinical deterioration, and places optimal CT severity assessment at least 72–96 hours after symptom onset. ACR criteria also note that CT is more reliable for assessing necrosis later in the course. Follow the local clinical pathway for protocol and timing.

Clinical safety note: CT describes morphology and local complications; the Revised Atlanta clinical severity class of mild, moderately severe, or severe cannot be assigned from imaging alone. An early CT without visible necrosis does not prove that necrosis will not develop later.

Systematic CT checklist

• Timing and protocol: Symptom onset or approximate day, indication, IV contrast, phase, prior examination, and image quality
• Pancreas: Size, contour, parenchymal homogeneity and enhancement, edema, and peripancreatic fat changes
• Necrosis: Location and extent of nonenhancing pancreatic parenchyma and/or peripancreatic necrosis. Do not exclude it confidently on an early or technically limited scan.
• Collection: Location, three dimensions, content (homogeneous fluid versus heterogeneous/debris-containing), presence and thickness of a wall, effect on adjacent structures, and time from symptom onset
• Vessels: Splenic, portal, and superior mesenteric vein thrombosis; arterial pseudoaneurysm or suspected hemorrhage
• Other complications: Biliary or gastric outlet compression, bowel involvement, ascites, pleural effusion, and extraluminal gas
• Impression: State the pancreatic morphology, the basis for the collection term, important complications, and limits of assessment

Use Atlanta collection terms with their supporting features

The Revised Atlanta Classification names collections based on time from symptom onset together with content, wall development, and the morphology of pancreatitis. Instead of writing only “cyst” or “fluid collection,” describe the observations that support the term.

Early in the course, APFC and ANC can be difficult to distinguish; do not force an early classification when timing and morphology are inconclusive. If solid content or duct communication is uncertain, MRI/MRCP may provide further characterization when clinically appropriate.

Complete report framework

Examination: CT abdomen and pelvis [with IV contrast / without IV contrast].
Indication: [Suspected acute pancreatitis / clinical deterioration / diagnostic uncertainty].
Symptom onset: [Date or approximate day].
Comparison: [Date / none available].

Technique: [Phases, contrast, and reconstructions]. [Limitation].

Findings: The pancreas is [size and contour]. Parenchymal enhancement is [homogeneous / heterogeneous; location of nonenhancing areas]. Peripancreatic fat shows [ ]. [No necrosis / location and extent of pancreatic or peripancreatic necrosis]. [Collection: location, dimensions, fluid/debris content, and wall]. Splenic, portal, and superior mesenteric veins are [ ]. Arterial complication/hemorrhage [ ]. Biliary tree, bowel, and adjacent-organ effects [ ]. Ascites/pleural effusion/extraluminal gas [ ].

Impression:
1. [Interstitial edematous / necrotizing pancreatitis morphology].
2. [Collection term under the Revised Atlanta Classification, with supporting appearance].
3. [Vascular or other local complication; timing or technical limitation].

Example 1 — interstitial pancreatitis with an early fluid collection

Fictional case. Contrast-enhanced CT was performed three days after symptom onset; no parenchymal necrosis is visible.

Examination: CT abdomen and pelvis with IV contrast.
Indication: Acute pancreatitis; persistent epigastric pain.
Symptom onset: Approximately 3 days earlier.
Comparison: None available.

Technique: Portal venous phase contrast-enhanced CT; axial images and coronal reformations reviewed.

Findings: The pancreas is mildly diffusely enlarged with homogeneous parenchymal enhancement. There is peripancreatic fat stranding and a homogeneous fluid collection without a defined wall extending into the left anterior pararenal space (5.1 × 2.4 cm). No nonenhancing pancreatic parenchyma or substantial necrotic debris. The splenic, portal, and superior mesenteric veins are patent. No pseudoaneurysm, active hemorrhage, or bowel obstruction. Small left pleural effusion.

Impression:
1. Interstitial edematous acute pancreatitis.
2. Homogeneous early collection without visible necrosis, compatible with an acute peripancreatic fluid collection (APFC).
3. Small left pleural effusion.

Stating that the collection is homogeneous fluid without a defined wall helps avoid prematurely calling it a pseudocyst.

Example 2 — necrotizing pancreatitis, WON, and splenic vein thrombosis

Fictional case. CT obtained five weeks after symptom onset shows an encapsulated heterogeneous collection and a vascular complication.

Examination: CT abdomen and pelvis with IV contrast.
Indication: Necrotizing pancreatitis; persistent fever and abdominal pain.
Symptom onset: Approximately 5 weeks earlier.
Comparison: CT from 10 days earlier.

Technique: Portal venous phase contrast-enhanced CT; axial images and multiplanar reformations compared at matching levels.

Findings: Nonenhancing parenchymal areas are present in the pancreatic body and tail. A thick-walled, heterogeneous fluid and debris-containing collection extends from the pancreatic bed into the left anterior pararenal space and measures 9.0 × 6.4 × 5.8 cm, previously 8.2 × 5.9 × 5.2 cm. No gas within the collection. The splenic vein is thrombosed adjacent to the collection; the portal and superior mesenteric veins remain patent. No pseudoaneurysm or active contrast extravasation. Small left pleural effusion.

Impression:
1. Necrosis of the pancreatic body and tail with an enlarging walled-off necrosis (WON).
2. Splenic vein thrombosis; portal and superior mesenteric veins are patent.
3. No gas within the collection or CT evidence of active hemorrhage.

Absence of gas does not exclude infection. Infected necrosis is assessed in the clinical and laboratory context; describe the imaging signs without making a clinical diagnosis or treatment decision.

Complications beyond collections

Name vascular findings separately: state which vein is thrombosed, how far the thrombus extends, and which major vessels remain patent. If an arterial pseudoaneurysm, active hemorrhage, or hematoma is suspected, lead with it in the impression and follow local critical-result communication policy. Report relevant biliary compression, gastric outlet narrowing, bowel involvement, ascites, and pleural effusion as well.

Describe morphology, necrosis location, and local complications instead of assigning a clinical class such as “severe pancreatitis.” Estimate the percentage of necrosis only when the method and image quality support it; it is not a mandatory field in every report.

Timing, protocol, and common pitfalls

If symptom onset is unknown, state that; do not substitute admission date for onset. Preserved enhancement or absence of a visible collection on an early CT does not show that the disease will not progress. If iodinated contrast was not used, state the limitation for assessing necrosis and vessel patency.

Do not choose a collection name from size or calendar day alone. The distinction between interstitial and necrotizing pancreatitis, homogeneous fluid versus debris, and wall development all matter. Classification may remain uncertain during the first weeks; “collection of indeterminate content” is more accurate than a definite but unsupported term.

Quick pre-sign-off check

• Is the interval from symptom onset to CT recorded?
• Are parenchymal enhancement and the location of necrosis described?
• Are collection size, content, wall, and anatomic extent stated?
• Do both timing and morphology support the Revised Atlanta term?
• Were vascular, hemorrhagic, biliary, and adjacent-organ complications reviewed?
• Does the impression avoid assigning clinical severity from imaging alone?

References

• International Association of Pancreatology, American Pancreatic Association, European Pancreatic Club, Indian Pancreas Club, and Japan Pancreas Society. International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025. Pancreatology. 2025;25(6):770–814. PubMed (opens in a new tab)
• Banks PA, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111. doi:10.1136/gutjnl-2012-302779. Article (opens in a new tab)
• Tenner S, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. Am J Gastroenterol. 2024;119(3):419–437. doi:10.14309/ajg.0000000000002645. Article (opens in a new tab)
• American College of Radiology. ACR Appropriateness Criteria®: Acute Pancreatitis (Revised 2019). Guideline (opens in a new tab)

Educational note: Cases are fictional and contain no patient data. This article does not replace clinical diagnosis, treatment decisions, local protocols, or specialist judgment.